Results 141 to 150 of about 53,783 (264)

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata   +3 more
wiley   +1 more source

Obesogenic effects of warm temperature involve feeding adaptation by preoptic area leptin receptor neurons. [PDF]

Commun Biol
Kaiser L, Lee N, Zaunbrecher K, Kinney C, Williams J, Smith M, Noland RC, Yu S, Morrison CD, Berthoud HR, Münzberg H.   +10 more
europepmc   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source

Precision nutrition in weight loss and neuroendocrine control of people with obesity: The study protocol of a factorial randomised controlled trial (GenON Programme). [PDF]

Diabetes Obes Metab
Balbino KP, Kravchychyn ACP, Cândido FG, Dias MME, Mendes TAO, Oliveira LL, Castro LCV, Bressan J, de la Garza AL, Milagro FI, Zulet MA, Hermsdorff HHM.   +11 more
europepmc   +1 more source

Antiobesity Potential of Selected Latin American Edible Plants: A Review. [PDF]

Plant Foods Hum Nutr
Hernández-Pérez T, Paredes-López O.
europepmc   +1 more source

Metabolic aspects of satiety [PDF]

Proceedings of the Nutrition Society, 1992
openaire   +2 more sources

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

Obesity, EarlyView.
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak, Arshdeep Rattol, Eduardo Grunvald   +2 more
wiley   +1 more source

Associations between Eating Behaviours and Psychological Characteristics with Body Mass Index Change and Appetite-Related Changes during Incretin-Based Therapy. [PDF]

Obes Facts
Kapan A, Haider S, Moser O, Waldhoer T, Felsinger R.   +4 more
europepmc   +1 more source

Interaction Between Genetic Risk and Parental Feeding Practices in the Prediction of Overweight Across Adolescence

Obesity, EarlyView.
ABSTRACT Objective We examined whether genetic risk for higher BMI, parental feeding practices (restriction, pressure to eat, and monitoring), and their interactions were associated with overweight trajectories during adolescence. Methods Data came from 5568 participants aged 10–18 in the Twins' Early Development Study who had at least one measurement ...
Marthe de Roo, Tina Kretschmer, Clare Llewellyn, Bonamy R. Oliver, Catharina A. Hartman   +4 more
wiley   +1 more source

Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections. [PDF]

Endosc Int Open
Li Z, Zhang S, Nie Y, Wang P, Liu B, Zhou B, Zhang N, Wang S, Chou S, Zhang L, Wang Z, Meng H.   +11 more
europepmc   +1 more source